FIELD: medicine, pharmacy. SUBSTANCE: agent is made as a solid dosed form, in part, tablet. Agent has the following components, wt.%: loratadin, 0.5-20.0; lactose, 53.8-98.3; microcrystalline cellulose, 1.0-25.0; and stearic acid salt, 0.2-1.2. To prepare agent loratadin and indicated accessory substances are mixed and prepared mixture is shaped. Agent is used by oral route and it releases an active component rapidly. This provides high rate of loratadin absorption that accelerates the onset of therapeutic effect of preparation. Invention can be used for treatment of patients with seasonal and year-round allergic rhinitis, conjunctivitis, pollinosis, nettle rash and other allergic diseases. EFFECT: enhanced effectiveness of agent. 5 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIHISTAMINE COMPOSITION | 2000 |
|
RU2165255C1 |
ANTIVIRAL AGENT AND METHOD OF PREPARATION THEREOF | 2000 |
|
RU2160105C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIHYPERTENSIVE ACTIVITY AND METHOD OF PREPARATION THEREOF | 2000 |
|
RU2169005C1 |
PHARMACEUTICAL COMPOSITION WITH SUSTAINED-RELEASE OF GLICLAZIDE | 2004 |
|
RU2273482C2 |
PHARMACEUTICAL COMPOSITION FOR ALLERGIC DISORDER TREATMENT | 2005 |
|
RU2283649C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIDEPRESSANT ACTIVITY | 2000 |
|
RU2174391C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT AND METHOD OF ITS PREPARING | 2000 |
|
RU2177318C1 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
FUNGICIDAL PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2237476C1 |
ANTICONVULSANT AND PSYCHOTROPIC AGENT AND METHOD OF ITS PREPARING | 1999 |
|
RU2157212C1 |
Authors
Dates
2001-04-10—Published
2000-05-25—Filed